Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2332523
下载链接
链接失效反馈官方服务：
资源简介：
To determine the recommended Phase 2 dose (RP2D) of TBio-6517 when administered by direct injection into tumor(s) or intravenously and when combined with pembrolizumab in patients with solid tumors (RIVAL-01).
创建时间：
2020-06-15
